High-dose tumor necrosis factor-alpha leads to the systemic inflammatory response syndrome.
Oldhafer
K J
KJ
Klinik für Abdominal- und Transplantationschirurgie, Klinische Molekularpharmakologie, Medizinische Hochschule Hannover, Germany.
Lang
H
H
Kuse
E R
ER
Martin
M U
MU
D000328:Adult; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy; D008297:Male; D018746:Systemic Inflammatory Response Syndrome / Q000139:chemically induced*; D014409:Tumor Necrosis Factor-alpha / Q000008:administration & dosage / Q000009:adverse effects*
D014409:Tumor Necrosis Factor-alpha